MD Office Solutions LLC Acquires Antigua Medical Services LLC: A Major Move in the World of Cardiac Mobile Imaging in Arizona

MD Office Solutions, LLC, Acquires Antigua Medical Services, LLC; a Cardiac Mobile Imaging Company in Arizona Introduction HAYWARD, Calif., Aug. 17, 2022 (GLOBE NEWSWIRE) — MD Office Solutions of Arizona, LLC, an Arizona based company, and subsidiary of M.D.O.S.C.A. Inc (“MDOS”), announced that it has acquired Antigua Medical Services, LLC. (“Antigua”) from Denise Nelson and…

Read More

ASP Isotopes Inc. Forms Strategic Partnership with Pet Labs Pharmaceuticals for Medical Isotope Distribution

ASP Isotopes Inc. Enters Strategic Relationship With PET Labs Pharmaceuticals for the Distribution of Medical Isotopes Introduction WASHINGTON, Oct. 29, 2023 (GLOBE NEWSWIRE) — ASP Isotopes Inc. (NASDAQ:ASPI) (“ASPI”, the “Company”, “us”, “we” or “our”), an advanced materials company dedicated to the development of technology and processes designed to produce isotopes for use in multiple…

Read More

Attention Investors: Don’t Miss the Deadline for the Xerox Holdings Corporation Class Action Lawsuit – A Reminder from Glancy Prongay Murray LLP

Deadline to File a Lead Plaintiff Motion for Xerox Holdings Corporation Investors Introduction: LOS ANGELES, Nov. 25, 2024 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 21, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise…

Read More

Discovering the Future of Non-Destructive Testing (NDT) Market: A Promising Growth of USD 23.2 Billion at 13.5% CAGR by 2030 – Market Research Future (MRFR) Report

Non-Destructive Testing (NDT) Market Continues to Grow NDT Services Increasingly Used in Aerospace and O&G Industries New York, US, July 28, 2022 (GLOBE NEWSWIRE) — According to a comprehensive research report by Market Research Future (MRFR), the NDT Services market is on the rise. With a projected valuation reaching USD … by the year 2030,…

Read More

Lilly’s Latest Acquisition: Enhancing Outcomes and Expanding Options for Those Living with Inflammatory Bowel Disease

Lilly’s Latest Acquisition: Enhancing Outcomes and Expanding Options for Those Living with Inflammatory Bowel Disease Description Broadening Lilly’s immunology pipeline with Morphic’s oral integrin therapies, including MORF-057. This acquisition reinforces the company’s strategy of delivering potential first or best-in-class therapies in the field of gastroenterology. INDIANAPOLIS, Aug. 16, 2024 /PRNewswire/ — Eli Lilly and Company…

Read More